CEN Case Reports is an influential journal published by Springer Japan KK, dedicated to advancing the knowledge and understanding of case reports across various scientific disciplines. The journal, identified by ISSN 2192-4449, focuses on disseminating high-quality, peer-reviewed case studies that illuminate unique clinical phenomena and contribute to the broader medical and scientific communities. Since its inception in 2018, CEN Case Reports has strived to provide a platform for researchers, professionals, and students to share groundbreaking findings while fostering collaborations across the globe. Although the journal currently does not adopt an open access model, it remains committed to accessibility through institutional subscriptions and individual purchase options. With a growing repository of insightful case reports, this journal plays a crucial role in enriching the evidence-based approach to medical practice and research, ensuring its relevance in a rapidly evolving field.

SAGE Open Medical Case Reports, published by SAGE Publications Inc, is a pioneering open-access journal dedicated to the rapid dissemination of medical case reports that significantly contribute to clinical knowledge and practice. Since its launch in 2013, this journal has become a valuable resource for healthcare professionals, researchers, and students in the field of medicine, facilitating the exchange of unique clinical experiences from around the globe. While the journal is categorized as Q4 in the Medicine (miscellaneous) quartile and holds a Scopus rank of 423 out of 636 in the General Medicine category, the accessibility of its content underscores its commitment to enhancing medical education and informing practice. With no subscription barriers, it supports the sharing of critical insights appropriate to a diverse audience, thereby fostering a culture of innovation and collaboration in healthcare.

JOURNAL DE MYCOLOGIE MEDICALE is a premier publication in the field of infectious diseases, particularly focusing on the study of mycology and its clinical implications. Published by MASSON EDITEUR, this esteemed journal is based in France and has been disseminating valuable research since its inception in 1994. With an ISSN of 1156-5233 and an E-ISSN of 1773-0449, it plays a critical role in advancing knowledge in mycological infections, positioning itself in the Q3 category for infectious diseases as per the 2023 quartiles. As indicated by its ranking in Scopus, ranking #142 out of 344 in the medicine-infectious diseases category, the journal maintains a prominent presence within the academic community, appealing to researchers, healthcare professionals, and students alike. Although access options are not open access, the journal endeavors to promote a deeper understanding of mycological studies that are crucial for combating ongoing and emerging infectious threats. As it continues to converge on new findings up to 2024, JOURNAL DE MYCOLOGIE MEDICALE remains an essential resource for those invested in the critical intersections of mycology and medicine.

Case Reports in Neurological Medicine is a premier open-access journal published by HINDAWI LTD, dedicated to advancing knowledge in the field of neurology through the dissemination of detailed case reports. Established in 2011, this journal provides a platform for researchers, clinicians, and students alike to share unique experiences and findings that contribute to the evolving landscape of neurological medicine. With an ISSN of 2090-6668 and an E-ISSN of 2090-6676, the journal promotes high-quality research that underscores the significance of individual cases in understanding complex neurological disorders. By ensuring open access to its content, Case Reports in Neurological Medicine enhances the visibility and impact of crucial clinical insights, fostering collaboration and innovation among professionals in the field. This commitment to accessibility and scholarly excellence makes it an invaluable resource for anyone keen to explore the intricacies of neurological medicine.

MYCOSES is a renowned academic journal published by Wiley, specializing in the fields of Dermatology, Infectious Diseases, and general Medicine, with a commendable focus on mycological research and its clinical implications. Established in 1957, this journal has significantly contributed to advancing our understanding of fungal diseases, offering a platform for high-quality research that ranks among the top in its categories—achieving Q1 status in Dermatology and Q1 in Medicine (miscellaneous), while maintaining a strong Q2 ranking in Infectious Diseases. With an impressive Scopus ranking of #5 in Medicine - Dermatology, MYCOSES occupies a pivotal position in the dissemination of critical findings and innovative practices within the scientific community. Although it is not an open-access journal, MYCOSES continues to attract a wide array of researchers, professionals, and students seeking to enhance their knowledge and keep abreast of the latest developments in mycology. Overall, MYCOSES not only serves as an essential resource for academia but also plays a vital role in shaping future research directions and clinical approaches to fungal infections.

Reports is a premier open access journal published by MDPI that has been committed to providing a platform for the dissemination of high-quality research since its establishment in 2019. With its E-ISSN of 2571-841X, the journal focuses on a wide array of subjects, aiming to bridge the gap between scientific innovation and practical application. Operating from its headquarters in Basel, Switzerland, Reports promotes transparency in research by offering open access options, ensuring that both researchers and the public can freely access cutting-edge findings. As an important resource in the academic community, it serves to facilitate collaboration and knowledge-sharing among scholars, professionals, and students alike, thereby enhancing the impact of research in various fields. The journal's commitment to rigorous peer review and scholarly excellence makes it a valuable asset for anyone looking to stay at the forefront of advancing science and innovation.

Therapeutic Advances in Infectious Disease is a distinguished journal published by SAGE Publications Ltd, dedicated to advancing knowledge in the vital field of infectious diseases and pharmacology. With an impactful Open Access model since 2019, the journal facilitates unrestricted access to a wealth of high-quality research, enabling researchers, clinicians, and educators to stay at the forefront of infectious disease management and treatment. As a recognition of its contribution to the scientific community, the journal holds a prestigious Q1 quartile ranking in both Infectious Diseases and Medical Pharmacology as of 2023, underscoring its influence and relevance in these domains. The journal is positioned favorably within the Scopus rankings, with an impressive standing in the diverse categories of Medicine, emphasizing its commitment to disseminating innovative research. Through a rigorous peer-review process and a broad scope that covers therapeutic advancements, Therapeutic Advances in Infectious Disease serves as an essential resource for anyone involved in combating infectious diseases, offering insights that drive clinical applications and enhance patient care.

Respiratory Medicine Case Reports is a dynamic open-access journal published by Elsevier, dedicated to the timely dissemination of case reports in the field of pulmonary and respiratory medicine. With an ISSN of 2213-0071 and a focus on innovative clinical practices, the journal serves as a crucial resource for researchers, clinicians, and students alike, contributing significantly to the advancement of knowledge in respiratory health. Since its inception in 2012, it has built a solid reputation within the academic community, currently ranking in the Q3 category in the field. The journal also holds a position within the 33rd percentile of its Scopus ranking, reflecting the quality and relevance of its published content. Situated in the United Kingdom and accessible globally, it provides a platform for the open exchange of ideas, encouraging submissions that enhance the understanding of complex cases and foster collaboration within the scientific community. Explore this resource to stay at the forefront of advancements in respiratory medicine and to contribute to the growing body of literature in this vital area.

Internal Medicine is a distinguished peer-reviewed journal published by the Japan Society of Internal Medicine, focusing on the nuanced field of internal medicine. Since its inception in 1974 and with a commitment to advancing medical knowledge, the journal has evolved remarkably, aiming to disseminate high-quality research that contributes to the understanding and treatment of internal diseases. Operating from Tokyo, Japan, it provides an intellectual platform for researchers and clinicians to publish original articles, reviews, and case studies that address various aspects of internal medicine. The journal currently holds a ranking in the Q3 quartile for both Internal Medicine and miscellaneous Medicine categories as of 2023, signifying its growing influence in the medical community. Although not an open-access journal, it remains accessible to a wide audience through institutional subscriptions, enhancing its reach among professionals and students alike. With its commitment to excellence, Internal Medicine serves as an essential resource for those seeking the latest developments and research within this vital medical field.

European Journal of Therapeutics is a distinguished journal dedicated to advancing the field of therapeutic sciences through high-quality research and innovative clinical practice. Published by Pera Yayincilik Hizmetleri, this interdisciplinary journal aims to facilitate knowledge dissemination in areas such as pharmacology, clinical medicine, and public health, thereby supporting both researchers and practitioners in improving therapeutic outcomes. Although the journal operates under a subscription model, its commitment to rigorous peer review ensures that published articles reflect the latest advancements and methodologies. With a growing emphasis on evidence-based therapies, the European Journal of Therapeutics serves as a vital platform for dialogue among healthcare professionals and researchers, enhancing the understanding of therapeutic interventions on a global scale. It welcomes contributions ranging from original research to review articles, making it an essential resource for those seeking to enrich their knowledge and influence practice in therapeutic approaches.